ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,000 | -72.5% | 34,236 | -53.7% | 0.00% | – |
| Q4 2021 | $80,000 | +15.9% | 74,014 | +94.6% | 0.00% | -100.0% |
| Q3 2021 | $69,000 | -34.3% | 38,028 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $105,000 | +4.0% | 39,585 | +40.7% | 0.00% | -75.0% |
| Q1 2021 | $101,000 | +42.3% | 28,134 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $71,000 | 0.0% | 28,134 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $71,000 | -24.5% | 27,992 | -2.1% | 0.00% | -25.0% |
| Q2 2020 | $94,000 | +34.3% | 28,598 | +0.2% | 0.00% | +100.0% |
| Q1 2020 | $70,000 | -47.8% | 28,528 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $134,000 | +9.8% | 28,418 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $122,000 | -26.9% | 28,418 | -0.9% | 0.00% | -25.0% |
| Q2 2019 | $167,000 | +111.4% | 28,666 | +39.0% | 0.00% | +100.0% |
| Q1 2019 | $79,000 | +113.5% | 20,619 | +3.5% | 0.00% | +100.0% |
| Q4 2018 | $37,000 | -38.3% | 19,929 | -0.5% | 0.00% | 0.0% |
| Q2 2018 | $60,000 | -13.0% | 20,021 | +13.1% | 0.00% | -50.0% |
| Q1 2018 | $69,000 | -6.8% | 17,703 | -1.6% | 0.00% | 0.0% |
| Q4 2017 | $74,000 | -27.5% | 17,994 | +8.1% | 0.00% | -33.3% |
| Q3 2017 | $102,000 | -2.9% | 16,647 | -1.0% | 0.00% | 0.0% |
| Q2 2017 | $105,000 | +11.7% | 16,807 | +12.9% | 0.00% | -40.0% |
| Q1 2017 | $94,000 | +17.5% | 14,883 | -0.2% | 0.01% | +25.0% |
| Q4 2016 | $80,000 | +9.6% | 14,910 | +15.6% | 0.00% | 0.0% |
| Q3 2016 | $73,000 | +9.0% | 12,897 | +0.5% | 0.00% | 0.0% |
| Q2 2016 | $67,000 | -25.6% | 12,837 | +6.3% | 0.00% | -55.6% |
| Q1 2016 | $90,000 | -2.2% | 12,074 | +9.6% | 0.01% | -18.2% |
| Q4 2015 | $92,000 | -15.6% | 11,013 | -8.7% | 0.01% | 0.0% |
| Q3 2015 | $109,000 | -23.2% | 12,067 | +1.7% | 0.01% | -21.4% |
| Q2 2015 | $142,000 | – | 11,866 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |